Amlodipine preserves the glomerular number in spontaneously hypertensive rats

Journal of Cellular and Molecular Medicine

Volumn 9, Issue 4, 2005, Pages 966-971

  Bezerra, Daniele G ^a   Pires, Karla M P ^a   Mandarim de Lacerda, C A ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Calcium channel blocker; Glomeruli number; Hypertension; Rat; SHR; Stereology

Indexed keywords

EID: 30944461785     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2005.tb00393.x     Document Type: Article

References (38)

1. rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285: 2719-28.
2. Douglas JG, Agodoa L. ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial. Kidney Int. 2003; 63: 74-6.
3. Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease - Results from the AASK trial. JAMA 2002; 288: 2421-31.
4. Akuzawa N, Nakamura T, Kurashina T, Saito Y, Hoshino J, Sakamoto H, Sumino H, Ono Z, Nagai R. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis. Am J Hypert. 1998; 11: 697-707.
5. Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchii Y, Uchida S, Kuwahara M, Yamazaki T. Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension - a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) study. Hypertens Res. 2004; 27: 21-30.
6. Gartenmann AC, Fossali E, von Vigier RO, Simonetti GD, Schmidtko J, Edefonti A, Bianchetti MG. Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney Int. 2003; 64: 1450-4.
7. Morrone LF, Ramunni A, Fassianos E, Saracino A, Coratelli P, Passavanti G. Nitrendipine and amlodipine mimic the acute effects of enalapril on renal haemodynamics and reduce glomerular hyperfiltration in patients with chronic kidney disease. J Hum Hypertens. 2003; 17: 487-93.
8. Kumagai H, Hayashi K, Kumamaru H, Saruta T. Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: A one-year, prospective, randomized study. Am J Hypert. 2000; 13: 980-5.
9. Kanazawa M, Kohzuki M, Yoshida K, Kurosawa H, Minami N, Saito T, Yasujima M, Abe K. Combination therapy with an angiotensin-converting enzyme (ACE) inhibitor and a calcium antagonist: beyond the renoprotective effects of ACE inhibitor monotherapy in a spontaneous hypertensive rat with renal ablation. Hypertens Res. 2002; 25: 447-53.
10. Karam H, Clozel JP, Bruneval P, Gonzalez MF, Menard J. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats. Hypertension 1999; 34: 673-8.
11. Kanno Y, Suzuki H, Okada H, Saruta T. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet. J Cardiovasc Pharmacol. 1994; 23: 480-4.
12. Dworkin LD, Tolbert E, Recht P.A., Hersch J.C., Feiner H., Levin R.I. Effects of amlodipine on glomerular filtration, growth, and injury in experimental hypertension. Hypertension 1996; 27: 245-50.
13. Black MJ, Briscoe TA, Constantinou M, Kett MM, Bertram JF. Is there an association between level of adult blood pressure and nephron number or renal filtration surface area? Kidney Int; 65: 582-588, 2004.
14. Black MJ, Wang Y, Bertram JF. Nephron endowment and renal filtration surface area in young spontaneously hypertensive rats. Kidney Blood Press Res. 2002; 25: 20-6.
15. Zimanyi MA, Bertram JF, Black MJ. Does a nephron deficit in rats predispose to salt-sensitive hypertension? Kidney Blood Press Res. 2004; 27: 239-47.
16. Skov K, Nyengaard JR, Korsgaard N, Mulvany MJ. Number and size of renal glomeruli in spontaneously hypertensive rats. J Hypertens. 1994; 12: 1373-6.
17. Amann K, Plank C, Dotsch J. Low nephron number-a new cardiovascular risk factor in children? Pediatr Nephrol. 2004; 19: 1319-23.
18. Menini S, Ricci C, Iacobini C, Bianchi G, Pugliese G, Pesce C. Glomerular number and size in Milan hypertensive and normotensive rats: their relationship to susceptibility and resistance to hypertension and renal disease. J Hypertens. 2004; 22: 2185-92.
19. Ots M, Troy JL, Rennke HG, Mackenzie HS, Brenner BM. Impact of the supplementation of kidney mass on blood pressure and progression of kidney disease. Nephrol Dial Transplant. 2004; 19: 337-41,.
20. Mandarim-de-Lacerda CA. Stereological tools in biomedical research. An Acad Bras Cienc. 2003; 75: 469-486.
21. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc. 1984; 134: 127-36.
22. Gundersen HJG. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J Microsc. 1977; 111: 219-27.
23. Barbuto N, Almeida JR, Pereira LM, Mandarim-de-Lacerda CA. Renal cortex remodeling in nitric oxide deficient rats treated with enalapril. J Cell Mol Med. 2004; 8: 102-8.
24. Alt JM, Hackbarth H, Deerberg F, Stolte H. Proteinuria in rats in relation to age-dependent renal changes. Lab Animals 1980; 14: 95-101.
25. Sharp PE, Regina MCL. The laboratory rat. Boca Raton Boston London New York Washington, D.C.: CRC Press; 1998.
26. Aguila MB, Mandarim-De-Lacerda CA. Effects of chronic high fat diets on renal function and cortical structure in rats. Exp Toxicol Pathol. 2003; 55: 187-95.
27. Bauer JH, Reams GP. Renal protection with calcium antagonism in essential hypertension. Clin Invest Med. 1989; 12: 300-4.
28. Berkels R, Taubert D, Bartels H, Breitenbach T, Klaus W, Roesen R. Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 2004; 70: 39-45.
29. Chou TC, Yang SP, Pei D. Amlodipine inhibits proinflammatory cytokines and free radical production and inducible nitric oxide synthase expression in lipopolysaccharide/interferon-γ-stimulated cultured vascular smooth muscle cells. Jpn J Pharmacol. 2002; 89: 157-63.
30. Ganafa AA, Walton M, Eatman D, Abukhalaf IK, Bayorh MA. Amlodipine attenuates oxidative stress-induced hypertension. Am J Hypertens. 2004; 17: 743-8.
31. Kato M, Matsumoto A, Nakajima T, Hirose K, Iwasawa K, Takenaka K, Yamashita H, Sugiura S, Hirata Y, Nagai R. Amlodipine increases nitric oxide production in exhaled air during exercise in patients with essential hypertension. Am J Hypertens. 2004; 17: 729-33.
32. Watanabe S, Ono H, Ishimitsu T, Matsuoka H, Ono Y, Fujimori T. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR. Hypertens Res. 2000; 23: 683-91.
33. Woods LL, Weeks DA, Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int. 2004; 65: 1339-48.
34. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988; 1: 335-47.
35. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med. 2003; 348: 101-8,.
36. Kett MM, Bertram JF. Nephron endowment and blood pressure: what do we really know? Curr Hypertens Rep. 2004; 6: 133-9.
37. Forrester T. Historic and early life origins of hypertension in Africans. J Nutr. 2004; 134: 211-6.
38. Jensen BL. Reduced nephron number, renal development and 'programming' of adult hypertension. J Hypertens. 2004; 22: 2065-6.